|
Introduction
Catalonia is an autonomous region in Spain with six million inhabitants.
By December 2000, 13 275 cases of AIDS had been reported and the annual
AIDS incidence rate was 81.8 per million in 2000. As a transmission
group, homosexual men represented 20% of the total number of AIDS cases
in 2000, showing a slight increase since 1998 (17.6%) (1). As part of
the Sistema integrat de vigilància epidemiològica de l’HIV/sida
a Catalunya (Catalan integrated surveillance system of HIV/AIDS), monitoring
of HIV and sexual risk behaviour among men who have sex with men (MSMs)
was introduced in 1993 (2).
Recently, different studies among MSMs have reported an increase in
HIV incidence (3-5) and sexually transmitted infections (6-8), and an
increase in sexual risk behaviour (9,10). This change to unsafe sexual
behaviour has been explained in part by the optimism surrounding HIV
treatment and the absence of the threat of death that existed a decade
ago. Some authors found a significant relationship between unprotected
anal intercourse and certain aspects of optimism in the context of new
HIV treatments (11-12).
The objectives of this paper are to describe the trends in prevalence
of HIV infection and in risk behaviour in 1995, 1998, and 2000 among
MSMs recruited in different venues in Barcelona; to describe trends
in knowledge and perception of antiretroviral treatment since 1998;
and to examine relationships between the practice of unprotected anal
intercourse and the perception of antiretroviral treatment.
Methods
Four cross-sectional surveys (1,2) have been carried out since 1993,
with the participation of a community-based gay organisation (Stop sida).
A convenient sample of MSMs was recruited each year in three saunas,
two sex shops, a pick up site in a public park and through a mailing
list of a community-based gay organisation. All venues were located
in Barcelona.
The questionnaire, used since 1995, was validated and adapted from
one developed by the Institut Universitaire de Médecine Sociale
et Préventive, Lausanne (13). It collects information about demographic
data, social network, sexual practices with steady and casual partners,
drug use, HIV testing behaviour, and, since 1998, knowledge and perception
of antiretroviral treatment and post-exposure prophylaxis. The behaviour
described refers to the 12 months before the survey.
Around 2000 anonymous self-administered questionnaires were distributed
each year by four health educators of a gay association. Questionnaires
were returned by mail. In addition, to estimate the prevalence of HIV
infection, around 300 saliva samples were requested each year to determine
HIV antibodies using standard enzymatic immunoassay techniques (14).
Furthermore, between 1000 and 1400 questionnaires were also sent to
all male members of a gay association in Catalonia.
A descriptive statistical analysis was performed using χ
2 for comparisons of proportions and logistic regression to adjust estimates.
The SPSS-PC V10 statistical software package was used. When differences
were not statistically significant between the three surveys, only the
results from the 2000 survey are presented. Unprotected anal intercourse
(UAI) with a steady partner and with casual partners was calculated
as the proportion of those who never or occasionally used a condom during
the previous 12 months when practising anal intercourse with steady
or casual partners. Statements about knowledge and perception of antiretroviral
treatment (ARV) had five response options: strongly agree (1), agree
(2), disagree (3), strongly disagree (4), do not know (5). For analysis,
options have been collapsed (1+2 = agree; 3+4 = disagree) and option
5 (do not know) has been removed.
Table 1
Age group, HIV testing and sexual behaviours of
men who have sex with men
| |
1995
(n = 741)
% (n/N)
|
1998
(n = 713)
% (n/N)
|
2000
(n= 828)
% (n/N)
|
p2
|
|
| Age group (years) |
|
|
|
|
| ≤ 19 |
0.6 (4/718)
|
0.6 (4/623)
|
0.6 (5/803)
|
|
| 20-29 |
35.5 (255/718)
|
28.7 (179/623)
|
22.2 (178/803)
|
< 0.001
|
| 30-39 |
42.1 (302/718)
|
45.1 (281/623)
|
47.6 (382/803)
|
|
> 40
|
21.9 (157/718)
|
25.5 (159/623)
|
29.6 (238/803)
|
|
| Already tested for HIV |
67.1 (497/741)
|
75.5 (529/701)
|
78 (637/817)
|
< 0.001 |
|
AOR1
|
1
|
1.5 [1.2-2.0]
|
1.7 [1.4-2.2]
|
|
| Self-reported prevalence
of HIV |
16.4 (78/475)
|
16.6 (87/524)
|
18.8 (117/622)
|
|
|
AOR1
|
1
|
0.9 [0.6-1.3]
|
1.1 [0.8-1.5]
|
ns
|
|
| Saliva prevalence of HIV |
14.2 (43/303)
|
15.5 (43/277)
|
17.9 (55/308)
|
ns
|
|
AOR1
|
1
|
1.1 [0.7-1.9]
|
1.3 [0.8-2.1]
|
|
| Number of male sexual partners |
|
|
|
|
| 0 |
2.2 (15/683)
|
2.7 (19/694)
|
0.8 (6/791)
|
|
| 1 |
14.5 (99/683)
|
12.4 (86/694)
|
10.9 (86/791)
|
|
| 2-10 |
38.1 (260/683)
|
30.7 (213/694)
|
30.5 (241/791)
|
|
| > 10 (11-450) |
45.2 (309/683)
|
54.2 (376/694)
|
57.9 (458/791)
|
|
|
AOR1 (<=10 vs >10)
|
1
|
1.3 [1.1-1.7]
|
1.7 [1.3-2.0]
|
< 0.001
|
|
| Unprotected anal intercourse
with steady partner |
53.2 (189/353)
|
52.2 (193/370)
|
58.9 (249/423)
|
|
|
AOR1
|
1
|
0.9 [0.7-1.3]
|
1.3 [0.9-1.7]
|
ns
|
|
| Unprotected anal intercourse
with casual partners |
24.2 (25/393)
|
21.8 (103/472)
|
25.4 (149/586)
|
|
|
AOR1
|
1
|
0.8 [0.6-1.1]
|
[0.8-1.4]
|
ns
|
|
| Ejaculation in steady partner's mouth |
20.1 (88/437)
|
25.2 (106/420)
|
29.3 (141/482)
|
|
|
AOR1
|
1
|
1.3 [0.9-1.8]
|
1.7 [0.3-2.3]
|
= 0.006
|
|
| Ejaculation in casual partners mouth |
7.2 (40/558)
|
7.1 (40/567)
|
12 (84/699)
|
|
|
AOR1
|
1
|
1.1 [0.7-1.8]
|
1.9 [1.2-2.8]
|
= 0.002
|
|
| Drug use before or during sex |
|
|
|
|
| Alcohol |
47.5 (335/706)
|
59.9 (398/669)
|
55.2 (430/779)
|
< 0.001 |
| AOR1 |
1
|
1.6 [1.3-2.1]
|
1.5 [1.2-1.9]
|
|
| Cannabis |
19.7 (141/717)
|
24.5 (160/653)
|
26.6 (204/766)
|
= 0.006 |
| AOR1 |
1
|
1.3 [0.9/1.7]
|
1.5[1.2/1.9]
|
|
| Cocaine |
9.6 (69/718)
|
16.7 (108/645)
|
22.5 (171/761)
|
< 0.001 |
| AOR1 |
1
|
1.9 [1.3/2.6]
|
3.0 [2.2-4.1]
|
|
| Ecstasy |
8.2 (59/716)
|
10.6 (68/642)
|
13.3 (100/754)
|
= 0.008 |
| AOR1 |
1
|
1.4 [0.9/2.1]
|
2.0 [1.4/2.9]
|
|
| Amphetamines |
1.3 (9/715)
|
3.3 (21/642)
|
3.9 (29/741)
|
= 0.006 |
| AOR1 |
1
|
3.0 [1.3/6.6]
|
3.7 [1.7/7.9]
|
|
| Poppers |
28.4 (204/718)
|
33.9 (223/657)
|
38.3 (298/778)
|
< 0.001 |
|
AOR1
|
1
|
1.2 [0.9/1.6]
|
1.6 [1.3-1.9]
|
|
|
ns: non significant
1 AOR: Adjusted Odds Ratio for age and 95% Confidence
Interval
2 Mantel-Haenzel χ
2
|
Table 2
Knowledge and perception (agrees versus disagrees)
regarding combined antiretroviral therapies (ARV). Comparison between
1998 and 2000. Logistic regression
| |
1998
(n = 713)
% (n/N)
|
2000
(n= 828)
% (n/N)
|
p1
|
AOR2
[CI]
|
|
ARV therapies can cure HIV infection
|
11.7 (58/495)
|
5.6 (31/556)
|
<0.001
|
0.4[0.3-0.7]
|
|
Side-effects of ARV therapies are very uncomfortable
|
70.2 (288/410)
|
83.5 (416/498)
|
<0.001
|
2.4[1.7-3.3]
|
|
HIV positive persons taking ARV are unlikely to transmit HIV
|
8.3 (40/482)
|
7.5 (40/535)
|
ns
|
0.9[0.6-1.5]
|
|
With ARV it is likely to avoid HIV infection after a potential
sexual risk exposure
|
7.4 (36/484)
|
21.5 (106/493)
|
<0.001
|
3.8[2.4-5.9]
|
|
Because of ARV MSM are less afraid of becoming HIV positive
|
34.4 (176/512)
|
46.1 (277/601)
|
<0.001
|
1.6[1.2-2.1]
|
|
Because of ARV I am less afraid of becoming HIV positive
|
22.4 (122/545)
|
30.2 (178/590)
|
=0.003
|
1.5[1.1-2.0]
|
|
Because of ARV MSM pay less attention to prevention
|
25.4 (133/523)
|
41.2 (249/604)
|
<0.001
|
2.2[1.7-2.9]
|
|
Because of ARV I pay less attention to prevention
|
6 (34/567)
|
11.4 (69/605)
|
<0.001
|
2.2[1.4-3.5]
|
|
Because of ARV MSM are less worried if they take sexual risks
|
21.6 (110/510)
|
30.8 (184/597)
|
<0.001
|
1.7[1.2-2.2]
|
|
Because of ARV I am less worried if I take sexual risks
|
7.2 (40/558)
|
11.6 (69/596)
|
<0.001
|
1.6[1.1-2.5]
|
|
ns: non significant
1 Mantel-Haenzel χ
2
2 AOR: Odds ratio ajusté par l’âge et
intervalle de confiance à 95% / Adjusted Odds Ratio for
age and 95% Confidence Interval.
Reference: 1998
|
Table 3
Association of unprotected anal intercourse (UAI)
with casual partners versus with casual partners with statements about
antiretroviral therapies ARV). Logistic regression
| |
UAI*
|
no UAI*
|
p1
|
AOR2 [CI]
|
|
HIV positive persons taking ARV are unlikely to transmit HIV
|
13.9 (21/151)
|
8 (45/564)
|
= 0.02
|
1.9[1.1-3.4]
|
|
With ARV It is likely to avoid HIV infection after a potential
sexual risk exposure
|
23.1 (33/143)
|
14.7 (79/538)
|
= 0.01
|
1.7[1.0-2.8]
|
|
Because of ARV I am less afraid of becoming HIV positive
|
40.7 (68/167)
|
25.7 (162/631)
|
< 0.001
|
1.9[1.3-2.8]
|
|
Because of ARV I pay less attention to prevention
|
29.1 (52/179)
|
6 (39/650)
|
< 0.001
|
6.2[3.8-10.1]
|
|
Because of ARV I am less worried if I take sexual risks
|
29.6 (50/169)
|
6.5 (42/644)
|
< 0.001
|
5.5[3.5-8.9]
|
|
ns: non significant
1 Mantel-Haenzel χ
2
2 AOR: Adjusted Odds Ratio for age and 95% Confidence
Interval.
* UAI: Unprotected anal intercourse
|
Results
The questionnaire return rate ranged from 29% (741/2543) in 1995 to
27% (713/2775) in 1998, and 24% (828/3445) in 2000. The mean age increased
over the years (33.7, 34.8, and 36.1 years old in 1995, 1998, and 2000,
respectively, p<0.001). With the exception of age, the selected samples
were similar for demographic characteristics. Most of them had a high
level of education (49% were university graduates) and were living in
Barcelona (70%).
The vast majority of the homosexual men studied had been tested for
HIV antibodies previously, and this proportion increased over the years
surveyed (table 1). We also observed an increase in the proportion of
those who had been tested more than once (40.9%, 50.9%, and 53.4% in
1995, 1998, and 2000, respectively). Self-reported prevalence of HIV
was 16.4% [95% confidence interval: 13.1-19.8] in 1995; 16.6% [13.4-20.5]
in 1998; and 18.8% [15.7-21.9] in 2000. Prevalence of HIV estimated
in the saliva samples was 14.2% [95% confidence interval: 10.3-18.1]
in 1995, 15.5% [11.3-19.8] in 1998, and 17.9% [13.6-22.2] in 2000. Although
both self-reported and saliva prevalence of HIV show an increasing trend,
neither are statistically significant.
Most respondents had sexual relationships with both steady and casual
partners (53%), more than a third with casual partners only (36%), and
11% with steady partners only. Nearly a third had sexual encounters
several times per week, and 14% irregularly, but with intensive periods.
Although the frequency of sexual activity seems to be stable, the number
of sexual partners shows an increasing trend. In 2000, 58% had more
than 10 sexual partners during the previous year (45% and 54%, respectively,
in 1995 and 1998, p<0.001). The association remains significant after
adjusting for age (table 1).
Anal intercourse was practised by 87% with a steady partner and 83%
with casual partners, and oro-genital sex by 98% and 96%, respectively.
Unprotected anal intercourse with a steady partner was reported by 59%,
and with casual partners by 25% (table 1). In both cases the proportion
of UAI showed a slight increasing trend, but was not statistically significant.
Similarly, we observed an increasing proportion of ejaculation in the
partner’s mouth that only remained significant for casual partners after
adjusting for age (table 1).
During the previous 12 months, 31% of the participants had experienced
at least one condom breakage and 22% condom slippage. The participants
who always used lubricants during anal intercourse had fewer accidents
with condoms than those who did not. However, less than half of the
men who used condoms during anal intercourse always used lubricants
(40%) and of these, 18% chose liposoluble lubricants (oil, petroleum
jelly, cream, etc) that can reduce the elasticity of the condom and
thus increase the risk of breakage.
Prevalence of drug use before or during sexual encounters in the 12
months before the survey was high and, with the exception of alcohol,
the use of drugs shows a clearly increasing trend over the years and
remained significant after adjusting for age (table 1).
Responses to statements about ARV are presented in table 2. Although
participants in 2000 seemed to be better informed, 5.6% still thought
that "ARV therapies can cure HIV infection". More respondents
than in the previous survey reported "side effects of ARV therapies
are very uncomfortable" (70.2% and 83.5% in 1998 and 2000, respectively).
In 2000, more MSMs had heard about post-exposure prophylaxis (PEP) than
in 1998: 21.5% believed that "with ARV it is possible to avoid
HIV infection after a potential sexual risk exposure" versus 7.4%
in 1998. In general in 2000, there was a more optimistic perception
regarding ARV therapy : a higher proportion than in 1998 believed that
"with ARV, MSMs are less afraid of becoming HIV positive",
and "pay less attention to prevention", and are "less
worried if they take sexual risks".
We found a significant association between the statements that suggest
optimistic perception of ARV therapy and unsafe sex, and this remained
significant after adjusting for age, year of survey, and known serological
status (table 3). Participants who agree that "HIV positive persons
taking ARV therapy are unlikely to transmit HIV" are 1.9 times
more likely to have UAI with casual partners, and those who agree that
"with ARV it is likely to avoid HIV infection after a potential
sexual risk exposure" are 1.7 times more likely. Similarly, those
who report "being less afraid of becoming HIV positive", "paying
less attention to prevention" or "being less worried if they
take sexual risks" are also more likely to have UAI (odds ratio
1.9, 6.2, and 5.5, respectively).
Comment
In general, the results of this fourth survey did not show significant
changes in the prevalence of HIV and in sexual risk behaviour of MSMs
surveyed in Barcelona. Only three indicators showed a statistically
significant increase: a higher proportion of participants than previous
surveys reported having had more than 10 male sexual partners in the
12 months before the survey; a higher proportion of ejaculation in the
mouth with casual partners; and a higher prevalence of drug use during
or before sexual encounters. This is not consistent with the recently
reported increase in both the HIV incidence rate (3-5) and in HIV risk
behaviour (9,10) among MSMs from other countries.
Although cross-sectional studies suffer from methodological limitations,
their repeated use over time with a standardised approach provides a
useful way to describe the evolution of the HIV epidemic among MSMs.
The return rate of questionnaires was not high, but was similar in the
three surveys, and higher than in ‰ other studies (13). We cannot, however,
generalise findings from this study to all MSMs in Barcelona. Self-reported
sexual behaviour may also be subject to measurement error, but we attempt
to reduce this by using an anonymous self-completed questionnaire.
The results of this fourth survey, however, still show a high prevalence
of HIV among MSMs in Barcelona, a high level of unprotected sex with
both steady and casual partners, and a high prevalence of drug use during
or before sexual intercourse. In addition, among those who used condoms,
accidents in the handling of condoms continued to be considerable and
despite educational campaigns, the use of liposoluble lubricants is
high. We also observed an increased trend of optimism regarding the
efficacy of HIV combination treatment, a decreased worry about HIV infection
because of PEP, and a significant association between optimism and UAI
with casual partners, as reported in other studies (11,12).
We conclude that there is no clear evidence of an increase in sexual
risk behaviour among MSMs, but the optimism regarding ARV may lead to
a greater relaxation in protective measures in the near future. In addition,
the high prevalence of HIV and risk behaviour, the difficulties to maintain
safer sex practices ("AIDS burnout"), the longer survival
of people infected with HIV, and the ineffectiveness of treatments due
to drug resistant HIV strains may make the control of the epidemic difficult.
Further and more creative interventions that take into account the new
scenario are needed.
Acknowledgements
The authors thank Stop sida, the association that carried out the survey
fieldwork, Kati Zaragoza, Rafa Muñoz, and all the men who voluntarily
gave their time to answer the questionnaire.
|